Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer

Affiliations

• ¹ Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: ronac.mamtani@pennmedicine.upenn.edu.
• ² Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania, Philadelphia, PA, USA.
• ³ Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA.
• ⁴ Flatiron Health, Inc, New York, NY, USA.
• ⁵ Merck & Co. Inc, Rahway, NJ, USA.